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Abstract 
MitoNEET is a [2Fe-2S] cluster protein found on the outer mitochondrial 
membrane. First discovered as a binding site for pioglitazone, an anti-diabetic drug, 
it was the first protein described containing a CDGSH iron-sulfur domain (ClSD). 
However, the function(s) of mitoNEET in both normal cellular physiology and the 
physiology in type-2 diabetes remains unclear. The proposed functions of 
mitoNEET, include cluster transfer, electron transport and oxidative respiration. 
This thesis describes the use of proteomic pull-down techniques to identify possible 
protein binding partners of mitoNEET from both mouse and human liver cell lysates. 
In order to accomplish this, the expression and purification of mitoNEET are also 
described. By analyzing the results of these pull-down experiments, we are able to 
categorize possible role(s) of mitoNEET through its interaction(s) with metabolic 
enzymes, proteins known to participate in cellular stress response and cancer cell 
signaling. 
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Introduction 
MitoNEET Discovery 
MitoNEET is a protein discovered in 2004 that is primarily found on the 
outer mitochondrial membrane (OMM) and was the first protein described as 
containing a 39AA CDGSH iron-sulfur domain (CISD). (Figure 1.) 1 
The CDGSH domain was 
annotated as a zinc-finger motif and 
subsequent CDGSH proteins 
discovered were Miner 1 (CISD2) and 
Miner 2 (CISD3) in humans.2 The 
crystal structures of mitoNEET show 
an intertwined homodimer with each 
of the monomers containing a [2Fe-2S] 
A 
Cluster 
Binding 
Oom01in 
Figure 1: Structural organization ofmitoNEET. 
(A)Backbone tracing of each protomer. (B) Ribbon 
diagram highlighting each domain. All iron-sulfur 
clusters are shown in space-filling using 
colorbyatom. 
cluster. The metal cluster is coordinated to the protein by 3-Cys (Cys-72, 7 4, 83) 
and 1-His (His-87) residue. z 
Miner 1 has a highly similar 
structure to mitoNEET (Figure 2).3 A 
mutation in the Miner 1 gene, created by 
the mis-splicing of mRNA that encodes 
this gene, has been found to be the 
causative agent in Wolfram Syndrome 2, Figure 2: Comparison of mitoNEET and Miner 1.3 
a disease characterized by juvenile onset diabetes mellitus, optic atrophy, deafness 
and an increase in bleeding tendency. 3 Miner 1 was initially reported to be located 
1 
in the endoplasmic reticulum (ER). However a recent study showed that it is 
primarily found in the outer mitochondrial membrane. 2 
Miner 2, also a mitochondrial protein, has been found to contain tandem 
CDGSH motifs. This is in contrast to the single CDGSH motif found in both mitoNEET 
and Miner 1. The function of Miner 2, however, has not yet been described. 2 
Because mitoNEET was discovered through a specific chemical probe, 
a derivative of the type-2 diabetes drug pioglitazone, the function of 
mitoNEET in a healthy cell and the dysfunction of mitoNEET in a cell afflicted with 
type-2 diabetes are unknown. A number of possible cellular functions have been 
implied from biochemical observations. The functions that led to the exploration 
described in this thesis are electron transport, iron-sulfur cluster transfer, 
reduction/oxidation regulation, and mediator of oxidative respiration. 
Iron-sulfur clusters are protein cofactors whose primary function is electron 
transport.4 These clusters transfer electrons one at a time by alternating oxidized 
(Fe+3, ferric iron) and reduced (Fe+2 ferrous iron) states of iron. Being consistent 
with mitoNEET's role as an electron carrier, it was shown that the mitoNEET UV-
visible absorption spectra changed reversibly in the oxidized and reduced states.4 
The [2Fe-2S] cluster enables us to have a spectroscopic handle that reports the 
immediate environment of the cluster. Rieske proteins, and other iron-sulfur 
containing proteins, are observed to have peaks in a range of (500-300nm) that are 
observable in the visible region. These are assigned as ligand to metal charge 
transfer (LCMT) bands.s (Figure 3.) Before the discovery of mitoNEET, the [2Fe-2S] 
clusters had been categorized as being either a Rieske-type protein, that has its 
2 
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Figure 3 Spectrum ofmitoNEET protein 
purified in the Konkle lab. The LMCT bands of 
the oxidized protein are highlighted. (Laffoon, 
Hirschfelder, Konkle, and Menze, unpublished 
results 
[2Fe-2S] cluster bound by 2-His and 2-
Cys residues or a ferredoxin type protein, 
where the [2Fe-2S] cluster is bound by 4-
Cys residues (Figure 4.).6 
In the case of Rieske proteins, the 
iron ligated to the histidine residue is the 
iron that will become selectively reduced. 
Therefore, the histidine residue plays an important role in the electron transport 
properties, in enabling cluster release, and in determining redox potentiaJ.6 At low 
pH, the ligating histidine residue(s) are formally uncharged. It is generally accepted 
that in high-potential proteins like the Rieske, 
they deprotonate when the pH is increased, 
yielding the reduction potential in a pH-
dependent manner.7 However, the [2Fe-2S] 
clusters that are ligated by four cysteine 
residues have pH-independent reduction 
H1s1~ His 13' HIS 87 Cys83 
~ y 1 
[2Fe-2S) / (2Fe-2$) 
,, 
, , 
"-
Cys151 Cys132 Cys74 Cysn 
Rieske Protein Cluster MrtoNEET Protein Cluster 
Figure 4 Comparison of the iron-sulfur 
cluster in Rieske protein and mitoNEET. 
potentials, as their ligands are always negatively charged and the clusters have the 
same charge as is in a fully deprotonated Rieske cluster.7 
MitoNEET's unique 1-His and 3-Cys coordination of the [2Fe-2S] cluster 
!ability is highly dependent on the presence of the single histidine ligand (His 87).8 
It has been shown that if the single His-87 ligand is replaced with a cysteine, the 
redox potential is decreased by approximately 300 mV and the stability of the 
cluster is increased by six-fold.9 The stability of this cluster with the mutant H87C 
3 
ligand was found to be best at pH>6. This suggests that the stability is pH-
dependent with regard to the protonation of His87 ligand. 9 
The evidence of cluster !ability indicated that mitoNEET may function as a 
iron-sulfur cluster transfer protein. Therefore, further investigations were required 
to determine whether mitoNEET is capable of cluster transfer to apo-acceptor 
proteins. It was reported that cluster transfer is possible between oxidized 
mitoNEET and apo-ferredoxin (a-Fd) 8 and was verified through UV-VIS 
spectroscopy, native-PAGE, and mitochondrial iron detections assay in cells. 
His87 plays an extremely important role in cluster stability. Analysis of UV-
visible spectrosopy shows that when His87 is replaced with a cysteine residue, 
(H87C) inhibits cluster transfer such that it will not transfer its [2Fe-2S] cluster to 
an a po-acceptor protein. This was further assessed to see if this was a result of an 
increase in cluster stability from the mutant H87C. Results showed that when a 
protein, KSSE, with similar kinetic stability was tested, it efficiently transferred the 
[2Fe-2S] cluster to a-Fd.8 
Cluster transfer is effective, when all of the pieces fall into place. However, if 
there are defects in the assembly of the cluster, there can be devastating results. 
Iron is a redox active and chemically reactive atom and an important element for all 
organisms to survive. Proteins have evolved that chaperone and facilitate the 
transfer of iron throughout cell compartments. If this does not take place, free iron 
in the system can be highly toxic. Defects in the iron-sulfur cluster assembly can 
have profound impacts on cell growth, excess iron accumulation, oxidative stress, 
and heme biosynthesis.10 The assembly of proteins that have an iron-containing 
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cofactor occurs mainly, but not exclusively, in the mitochondrial matrix of 
eukaryotic cells.1° 
Development of type-2 diabetes is associated with insulin resistance as a 
result of mitochondrial dysfunction, including disrupted iron homeostasis. 11 
Pharmacologic agents, such as thiazolidinedione (TZD), are commonly used to treat 
this resistance. Pioglitazone, trade name Actos, is a member of the 
thiozolidinedione (TZD) class of drugs that are used in the treatment of type-2 
diabetes.12 (Figure 5.) This class of drugs was approved as ligands of peroxisome 
proliferator-activated receptor subtype gamma (PPAR-Y). There is evidence to 
suggest that many clinical effects of TZD's originate by binding to mitoNEET.8 
Pioglitazone is known to enhance oxidative capacity and normalize metabolism by 
lowering circulating lipids. Initially, these drugs were thought to operate by binding 
Pioglitazone 
Figure 5: Chemical structure of 
pioglitazone. (Chem Works) 
to PPARs. Through research by JR Colca, an 
additional binding site was found within the 
mitochondrial membrane, and mitoNEET was 
identified.11 Pioglitazone has been shown to inhibit 
iron transfer from mitoNEET to mitochondria, thus 
indicating it affects a specific property, the transfer of [2Fe-2S] cluster in the cell 
environment.8 MitoNEET was shown to easily transfer the [2Fe-2S] cluster to 
acceptor proteins, namely apo-Ferrodoxin (a-Fd), a universal acceptor protein, only 
under oxidizing conditions.8 In in vitro experiments, it has been found that the 
presence of pioglitazone increases the stability of the cluster.10 
5 
Another important consideration of mitochondrial and cellular redox is the 
homeostasis of the molecules 
NAD(H)/NADP(H). (Figure 6.) NADPH is 
produced in fatty acid degradation and the citric 
acid cycle. It is part of the oxidative phase of 
the pentose phosphate pathway. There are 
three major biological functions of NADPH. The 
first is that it plays a major role in cellular anti-
I- .. 
- =o {...h I ... N v 
R• i\., • NADH 
~zNAOPH 6-
Figure 6 : Structures ofNAD(H) and 
NADP(H) 
oxidation system, the second is an electron source for reductive synthesis of fatty 
acids, DNA and steroids, and third is that it acts as the substrate for NADPH oxidases 
that play major roles in many biological and pathological pathways by generating 
reactive oxygen species (ROS).13 NAO+, like NADPH, is a coenzyme that is redox 
active. NADPH is mostly found in cytosol, whereas NAO+ is found in the 
mitochondria while NADPH inhibits (2Fe-2S] cluster transfer from mitoNEET to an 
apo-acceptor protein, NAO+ does not cause a loss of (2Fe-2S] cluster.14 NMR titration 
experiments reveal that NADPH weakly binds to mitoNEET and the clusters are 
destabilized by the side chain conformation of KSS and H58 residues present in 
mitoNEET.14 Since mitoNEET has the ability to transfer its (2Fe-2S] cluster to apo-
acceptor proteins, it would be interesting to see what effect NADPH has on cluster 
transfer. It was also found that NADPH binding to mitoNEET causes a negative shift 
in the redox potential in a similar manner that was observed for TZD binding. This 
suggests that His-87 is involved in the NADPH binding.15 Although a control was 
used to observe redox changes in the presence of NADH, which does not bind to 
6 
mitoNEET, no changes were found. This suggests that the additional phosphate 
group of NADPH is essential for binding NADPH to mitoNEET.15 
The redox properties of mitoNEET are pH-dependent. Research was 
conducted to explore whether NADPH binding to mitoNEET affects the pH profile. 
Results showed a dramatic redox shift for mitoNEET in the presence of NADPH, at 
pH<7.0 and less at pH>7.0.15 This indicated that binding NADPH shifts pKox from pH 
6.8 to pH 7.8, whereas E acid shifted -40mV. The negative change was verified 
through the addition of several negative charges from the phosphate groups on 
NADPH. The placement of this negative charge near the [2Fe-2S) cluster 
discourages further addition of negative charge that results from single electronr 
reduction that results in a lower measured value for E acid.16 It was previously 
proposed that pKox is due to protonation of His-87, and results suggest that binding 
of NADPH may involve His-87.15 In summary, NADPH has a potential role in 
regulating mitoNEETs [2Fe-2S) cluster as well as to inhibit transfer of this cluster to 
apo-acceptor proteins. 
Mitochondria are the powerhouses for cells. They contain two membranes, 
an outer membrane and inner membrane. The membranes are separated by a small 
space. The inner membrane surrounds the mitochondrial matrix where oxidative 
phosphorylation takes place. (Figure 7.) Electrons are produced through the citric 
acid cycle by traveling from one protein complex to the next. Oxygen is the last 
recipient of electrons through this transport chain and water 
7 
is produced. At the same time, the electron transport chain is producing ATP. 
Research has shown that mitoNEET, located on the outer mitochondrial membrane, 
plays an important role in 
regulating electron transport 
and oxidative phosphorylation.12 
Analyses have shown that the 
mitochondria from mitoNEET-
null heart tissue of mice have 
Figure 7 : Mitochondrial matrix wi th inner and outer 
membrane. (Google image, oregonstate.edu) 
reduced oxidative capacity. It 
was suggested that mitoNEET is 
an important iron-containing protein that is involved in the control of maximal 
mitochondrial respiratory rates. It was also noted that the mechanism to achieve 
this is unclear. 12 
Glutathione has several important cellular roles. It is a major antioxidant in 
cells, regulates the nitric oxide cycle and it is used in metabolic and biochemical 
reactions such as; DNA synthesis and repair, amino acid transport, protein synthesis, 
protein protein 
HS) 
) 
reduced S oxidized 
(free thiol) HS~ ~ (disulfide) l 
-protein protein 
Figure 8: Oxidized and reduced thiol 
group in glutathione. (Stemwiki 
Hyperlibrary) 
and enzyme activation.17 (Figure 8.) 
Glutathione can be synthesized by amino acids 
such as glycine, L-glutamic acid, and L-cysteine. 
The thiol group (S-H) serves as a proton donor 
and is responsible for the biological activity of 
glutathione. The rate-limiting factor in 
glutathione is cysteine.18 The reduction of mitoNEET [2Fe-2S] cluster has shown to 
8 
be accomplished by the addition of biological thiols and reversibly oxidized by 
hydrogen peroxide.19 In vitro studies show that purified mitoNEET [2Fe-2S] 
clusters can be partially reduced by glutathione.19 The clusters can be fully reduced 
by dithiothreitol or the E-Coli thioredoxin/thioredoxin reductase system under 
anaerobic conditions.19 The thiol-reduced mitoNEET [2Fe-2S] clusters can be 
reversibly oxidized by hydrogen peroxide.19 This suggests that mitoNEET may act 
as a sensor of oxidative signals in order to regulate mitochondrial functions through 
its clusters. This does not disrupt the cluster binding of mitoNEET in vitro and in E. 
coli cells.19 
Studies have shown that iron-sulfur clusters in regulatory proteins can 
undergo redox transition in their response to oxidative signals without disrupting 
the cluster.19 MitoNEET was put to the test by incubation with increasing 
concentrations of hydrogen peroxide. Findings revealed that the clusters remained 
unchanged, thus indicating their stability in the presence of hydrogen peroxide.19 In 
determining whether pre-reduced mitoNEET could be oxidized by hydrogen 
peroxide, experiments using prereduced mitoNEET with excess dithiothreitol under 
anaerobic conditions were performed. This was done to diminish any possible 
effect that NADPH would have on the mitoNEET clusters.19 As expected, the 
prereduced mitoNEET {2Fe-2S] clusters were oxidized with the addition of the 
hydrogen peroxide.19 
Proteins are very large biological molecules that consist of long chains of 
amino acid residues. These chains differ in length and sequence, depending upon 
the protein. Protein functions also vary due to their numerous roles in living 
9 
organisms. Separation methods vary for proteins due to their amino acid sequence 
and the chemical characteristics of that particular protein. These characteristics 
include molecular weight, charge, solubility and biological affinity. The purification 
strategy depends upon the characteristics of the target protein. Ideally, the 
purification process will yield the maximum amount of target protein with 
maximum loss of contaminating proteins. This process may take several steps 
because of the number of other contaminating proteins that are present along with 
the target protein. 
One method that is used in protein purification is affinity chromatography. 
(Figure 9.) Affinity chromatography is a means of separating the target protein 
from the product mixture. This technique relies heavily on interaction between 
molecules with a ligand bound to a matrix. One of the most commonly used affinity 
techniques is the hexahistidine tag. One can add the codons for six histidines to the 
end of a gene that encodes the protein of interest. After expression in bacteria, the 
protein will have six extra histidine residues. Histidine contains two nitrogen atoms 
that have a natural affinity for divalent cation metals. The column that is commonly 
used contains a nickel (Ni2+) resin. 
There are three steps involved in the protein purification process. The first 
step is loading the protein onto the column in a buffer with a low concentration (10 
mM) of imidazole. lmidazole is an organic molecule that is the same as the side 
chain of histidine. The second step involves "washing" away the non-bound sample 
from the support. Using appropriate buffers that will maintain the binding 
interaction of the target protein and the column is extremely important in this step. 
10 
This balance is accomplished by increasing the 
concentration of imidazole to an intermediate 
concentration (20 mM). The last step involves 
dissociating the target protein from the 
immobilized ligand using a very high 
concentration of imidazole (250 mM) so that is no 
longer bound and can be eluted from the column 
and collected. 
One of the most helpful tools in 
determining the purity of the target protein 
Figure 9: Affi nity 
chromatography with nickel 
colum n. Goo le ima es, wiki 
yield is through a process called denaturing gel electrophoresis (SOS PAGE, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis). Samples are applied to a gel 
matrix and are separated by size using the application of an electric field to the 
proteins that have been made linear and uniformly negative by the addition of SOS 
detergent. These are then stained so the proteins can be visualized and specific 
proteins can be determined according to weight. The anticipated result 
of a gel after purification is that there 
would only be one band, indicating the 
presence of only one protein. (Figure 
10.) 
Having some knowledge of 
mitoNEETs functions, we hope through 
15kDa 
JOkDa 
Figure 10: Gel of purified mitoNEET 
fractions from a HisPur column . 
(Roberts, Hirschfelder, Konkle and 
Menze, unpublished results) 
expression, purificatation and protein analysis, to be able to piece together 
11 
interactions with other proteins and learn more about the mysteries of this special 
protein. 
12 
Materials and Methods 
The materials and methods were adapted from Roberts et. al.20 
Expression and Purification of MitoNEET 
The plasmid containing the cleavable hexa-hjstagged mitoNEET gene in a puc 
19 vector was provided by Dr. Max Funk, University of Toledo, and expressed 
according to the published protocol.21 The culture was spun down at 10,000 RPM 
for 10 minutes at 4° C and pelleted cells were red in color. The pellet was washed 
with 10 mL of a phosphate buffered saline solution and centrifuged again at 10,000 
RPM for 10 minutes at 4° C. Cells were re-suspended with a pre-lysis mixture of 
Tris-HCI (0.05 M, pH 8.5, Fisher Bioreagents, Fairlawn, NJ), sodium chloride (0.3 M 
Fisher Bioreagents, Fairlawn, NJ), imidazole (10 mJ, Sigma-Aldrich, St. Louis, MO), 
BME (O.OOlµL/mL, Acros Organics, Fairlawn, NJ), DNase (20 µg/mL, Sigma-Aldrich, 
St. Louis, MO), RNase (20 µg/mL, Sigma-Aldrich, St. Louis, MO), and 
phenylmethylsulfonyl fluoride, (PMSF, 100 µg/mL, Sigma-Aldrich, St. Louis, MO) at 
pH 8.5. The suspended cells were stored at -80° C until further purification was 
required. 
Chemical lysis was accomplished using lysozyme from chicken egg white ( 4 
mg/mL, Fisher Bioreagents, Fairlawn, NJ) and triton X-100 (0.1 %, lntegra, Renton, 
WA). The lysis mixture was shaken for 1hat4° C. The mixture was then spun 
down at 30,000 RPM for 40 minutes at 4° C and the red-colored supernatant was 
retained and stored at -80° C. A HisPur Ni-NTA chromatography cartridge 
(ThermoFisher, Waltham, MA) was used with 20 mL buffer A, 4 column volumes: 
50mM trisHCl, 300 mM NaCl, and 10 mM imidazole, then 20 mL buffer 8, 4 column 
13 
volumes: 125mM trisHCl, 750 mM NaCl, and 20 mM imidazole, and finally, 20 mL 
buffer C, 4 column volumes: 125 mM trisHCl, 750 mM NaCl and 250 mM imidazole. 
The column was first washed with 20 mL water, in 4 column volumes, and not 
collected. 20 mL of buffer A was washed through the column and collected. (Tubes 
1-3). The sample was loaded into the column, and 2 test tubes of flow through were 
collected. The column was washed with 20 mL of buffer A and 7 test tubes were 
collected in 3 mL fractions. 15 mL of buffer B was then washed through the column 
in 3 mL fractions and 5 test tubes were collected. 30 mL of buffer C was washed 
through in 1.5 mL fractions until the solution was red and then 0.5 mL fractions 
were collected in approximately 21 test tubes. 
The red fractions eluted from the column with the 250 mM concentration of 
imidazole were analyzed by SDS-PAGE gel electrophoresis ( 4-15% TGX, Bio-Rad 
Corporation, Hercules, CA). For long-term storage, purified mitoNEET was dialyzed 
into 50 mM phosphate buffer at pH 8.5 immediately after elution from the column to 
improve stability. The protein was stored at -80 ° C. 
MitoNEET Pull-Down Experiment 
A pull-down experiment using hexa-histagged mitoNEET was accomplished 
using ProFound Pull-Down PolyHis Protein: Protein Interaction Kit (Thermo-Fisher, 
Waltham, MA) following the manufacturer's protocol. In brief, hexa-histagged 
mitoNEET, at a concentration of 19 µM was used as the "bait" protein. Two different 
experiments were conducted; one using mouse liver cells as the "prey" and the other 
using the human hepatocellular liver carcinoma cell line HepG2. The entire liver 
was excised from a C57BL/6J black mouse immediately after the mouse was 
14 
sacrificed. (Mouse liver supplied by Will Fernandez, Menze Laboratory, Biological 
Sciences, Eastern Illinois University.) To obtain the largest quantity of cells, the 
entire liver was used (-1 gram). The liver was washed with tris-buffered saline 
(TBS) at pH 7.4 in order to remove excess blood and manually homogenized with an 
additional 5 mL of TBS buffer on ice. The mouse liver lysate was then prepared 
using a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) following the pull-
down protocol from the homogenized mouse liver in TBS buffer supplied by the 
manufacturer. The human hepatocellular liver carcinoma cell line, HepG2 (ATCC 
HB-8065, Manassas, VA), was cultured to confluence (-25 million cells), trypsinized 
and suspended in 5 mL of DMEM (Life Technologies, Madison, WI) and lysed 
according to the manufacture's protocol to give the mammalian cell lysate. 
Two controls were done for each pull-down experiment. The first control 
was run with just the bait protein, mitoNEET. The second only used prey, mouse 
liver lysate or HepG2 lysate. The third sample had bait and prey, mitoNEET and 
either mouse liver lysate or HPG2 lysate. A SOS-PAGE gel ( 4-15% TG, Bio-Ra, 
Hercules, CA) was run with the three different elution samples. A 37.1, 70, and 75 
kDA band, unique to the bait-prey sample, was excised from both mouse and human 
liver cell lysate experiments and identified. 
Identification of Pull-down Proteins using Proteomics 
The SOS-PAGE gel slice was divided in two. Each slice was destained and 
then digested by trypsin (Promega, Madison, WI) or trypsin and GluC (Bioline, 
Taunton, MA) overnight at 37° C. Digest peptides were extracted from the gel slices 
with 1) 50% ACN/49.9% Hz0/0.1 % TFA and/or 2) 99.9% CAN/0.1 % TFA. 
15 
Tryptic peptides were injected onto the C18 column using a L TA (Thermo-
Fischer Scientific, Pittsburgh, PA) and UPLC system (Waters, Milford, MA). A 
NanoAcquity UPLC® Trap Column 180µm x 20mm x 5 µm was used. Peptides were 
eluted with a linear gradient from 3 to 40% acetonitrile (in water with 0.1 % formic 
acid) developed over 65 minutes at room temperature, at a flow rate of 500 
nL/min, and effluent was electro-sprayed into the L TQ mass spectrometer. Blanks 
were run prior to the sample run to ensure there was no significant signal from the 
solvents or column. Database search was carried out using SequestTM algorithms 
(Proteome discoverer vl.3). 
Protein annotation with proteomic identification numbers (IP numbers) and 
sample number were supplied by Proteomics Center at the Indiana University 
School of Medicine (Indianapolis, IN) .. Using the ID numbers from each protein 
annotation, the Enzyme Commission (EC) number was searched for online, using 
different protein databases including Uniprot (www.uniprot.org), Brenda 
(www.brenda-enzymes.org), and Kegg (www.genome.jp/kegg/). The EC number is 
a classification scheme for enzymes based on the chemical reactions they catalyze. 
It is also associated with a recommended name for the respective enzyme. (ExPASy, 
Bioinformatics Research Portal, www.expasy.org). There are enzymes that catalyze 
several different reactions, making it difficult to assign one EC number for that 
particular enzyme. There were many proteins that were not assigned EC numbers, 
because not all proteins are enzymes, or had a partial number listed at this time. 
Using a protein atlas from Sigma Aldrich (www.sigmaaldrich.org), as well as The 
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Human Protein Atlas (www.proteinatlas.org), the EC numbers were used to find the 
metabolic pathways. These pathways were noted. 
Each protein found was searched in Pubmed (www.ncbi.nlm.gov/pubmed/) 
via the IP number, the EC number or the protein annotation. Articles pertaining to 
that particular protein were researched. Functions, descriptions or pathways of 
each protein were noted. 
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Results 
Expression and Purification of Human MitoNEET 
The plasmid containing the cleavable hexa-histagged mitoNEET was 
expressed in bacterial cells. The culture was spun down and the pelleted cells were 
red. The cells were re-suspended with a pre-lysis mixture of buffer (Tris-HCI), salt 
(Na Cl), column ligand (imidazole ), reductant (Beta-mercaptoethanol, BME), nucleic 
acid degrading enzymes (DNase, RNase) and a protease inhibitor 
(phenylmethylsurfonyl fluoride) at pH 8.5. These cells were stored at -80°C. 
Chemical lysis was performed and the red colored supernatant was kept and stored 
at -80°C. 
MitoNEET was purified by affinity chromatography. A step-gradient of 
buffers was used with a nickel chromatography cartridge. The buffers used all 
250 -r--------.--------------
c 
.:: 
~ 200 
... 
c 
Q> 150 ;---------- -------~ :;: 
8 e 
Q> 100 ;---------- -------
0 
N 
~ 50 +--------- -------] 
0 2 4 6 8 10 12 14 
Volume (Column Volume) 
Figure 11: Method for the purification of mi to NE ET by 
affinity chromatography 
contained a buffering 
molecule (Tris), salt 
(NaCl) and imidazole . 
As the column 
method progresses, 
the concentration of 
imidazole is 
increased from 10 
mM-250mM 
(Figure 11.) The red 
fractions were eluted from the column with the buffer containing 250 mM imidazole. 
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A reducing denaturing gel of the fractions from the column indicated that 
mitoNEET was pure as a single band with-12 kDa molecular weight. 
Identification of Protein Binding Partners of Mi to NE ET A pull-down 
experiment was done using hexa-
histagged human mitoNEET. 
MitoNEET was the "bait" protein and 
the liver lysates were the "prey". 
Two controls were done for each 
experiment. The first was mitoNEET, 
the bait, and the second was the prey, 
--
-
s 
Sample 
1. MW Ladder 
2. Wash Steps 
3. Prey 
,4. Bait + Prey 
5. Bait 
Figure 12: Pull-down gel results from the mouse liver 
lysate. The molecular weight ladder is in sample 1, wash 
elution steps in sample 2, the mouse liver lysate-control 
in sample 3, mitoNEET and mouse lysate in sample 4, and 
the mitoNEET control in sam le 5. 
mouse liver lysate. The third sample had both bait and prey. Lysates used were 
either from mouse liver (courtesy of Will Fernandez, Menze lab) or from human 
hepatocarcinoma cells (HepG2, courtesy of Will Fernandez, Menze Jab). The SOS-
PAGE gel was run to analyze the wash steps, bait-only control, prey-only control, 
and bait+prey. 
From the mouse samples, four bands were excised from the gel (Figure 12.) 
and submitted to Indiana University School of Medicine Proteomics Center 
(Indianapolis, Indiana). The bands at - 13 (Table 1.) and 26 (Table 2.) kDa were 
extracted as a positive control for mitoNEET. Bands that were exclusively in the 
bait-prey Jane (Figure 12, lane 4) were identified at - 70 (Table 3.) and 75 kDa 
(Table 4.). Proteins in these bands were sequenced and the identification provided 
by Indiana University Proteomics Center in spreadsheet form with the name of the 
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protein, the proteomics ID number (IP number), and the number of peptides found. 
In total 29 mouse proteins were identified. 
Proteomics Results - Mouse Liver Lysate 
T bl 1 P a e roteom1c resu It f s rom sam I 1 pe 
Protein Protein MWappt ID EC Peptides q value 
Number Annotation Number Number Identified 
1 30S ribosomal 
subunit protein 
SlS [Shigella 
flexneri 2a str. -13 kDa gi :16131057 2 5.34E-06 
2457T] 
305 ribosomal subunit protein 515 [5higella flexneri 2a str. 2457T], (Table 1. 
no. 1), probable bacterial contamination or misidentification. 
T bl 2 P a e f 1 2 roteom1c resu ts rom samp e 
Protein Protein MWappt ID EC Peptides q value 
Number Annotation Number Number Identified 
2 Glutathione 
peroxidase 1 - 24 kDa IPI00319652.2 1.11.1.9 3 4.52E-09 
3 CDGSH iron su lfur 
domain-
containing protein - 24 kDa 
1 IPI00128346.1 2 1.39E-08 
Glutathione peroxidase 1, GPXl, (Table 2. no. 2), belongs to the group of 
peroxidases that eliminate hydroperoxides. It reduces lipid hydroperoxides to their 
corresponding alcohols and reduces free hydrogen peroxide to water.22 Peroxides 
are highly reactive molecules that can cause damage to proteins and DNA, therefore 
GPXl protects the organism from oxidative damage. CDG5H iron sulfur domain-
containing protein 1, CI5Dl, (Table 2. no. 3), is an alternative name for mitoNEEr.12 
This was a successful identification of a positive control. 
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T bl 3 P a e f I 3 roteom1c resu ts rom samp e 
Protein Protein MWapp1 ID EC Peptides q value 
Number Annotation Number Number Identified 
4 Catalase - 70 kDa 1PJ00869393.1 1.11.1.6 22 1.28E-06 
5 Putative 
uncharacterized 
protein - 70 kDa IPJ00122815.3 19 2.94E-07 
6 Carboxylesterase - 70 kDa 
3 IPJ00387289.3 3.1.1.1 13 1.28E-06 
7 Methylmalonate-
semialdehyde 
dehydrogenase 
[ acylating]. 
mitochondrial - 70 kDa IPJ00461964.3 1.2.1.18 13 2.12E-06 
8 Protein disulfide-
isomerase A3 - 70 kDa IPJ00230108.6 5.3.4.l 7 2.lZE-06 
9 Isoform 1 of 60 
kDa heat shock 
protein, - 70 kDa 
mitochondrial IPJ00308885.6 7 l.15E-06 
10 Aldh4al protein - 70 kDa IPJ00460335.1 1.5.1.12 5 1.25E-06 
11 Heterogeneous 
nuclear 
ribonucleoprotein - 70 kDa 
L IPJ00620362.4 5 1.25E-06 
12 Delta-1-pyrroline-
5-carboxylate 
dehydrogenase, 
mitochondrial - 70 kDa !PJ00405699.2 1.2.1.88 5 1.2SE-06 
13 Isoform 1 of Acy!-
coenzyme A - 70 kDa 
synthetase 
ACSMl, 
mitochondrial IPJ00126625.1 6.2.1.2 5 1.25E-06 
14 Glutamate 
dehydrogenase 1, 
mitochondrial - 70 kDa IPJ00114209.l 1.4.1.3 5 1.25E-06 
15 Amine Oxidase 
[flavin- - 70 kDa 
containing] 8 IPJ00226140.5 1.4.3.4 5 l.25E-06 
16 2-hydroxyacyl-
CoA lyase 1 
- 70 kDa IPJ00316314.1 4.1.-.- 5 1.25E-06 
17 MCG23407 - 70 kDa IPJ00154043.1 3.1.1.88 4 1.25E-06 
18 Calreticulin 
- 70 kDa IPJ00123639.l 3 1.25E-06 
19 Beta globin - 70 kDa IPJ00762198.2 2 2.25E-06 
20 Choline 
dehydrogenase, 
mitochondrial - 70 kDa IPJ00273146.l 1.1.99.1 2 l.15E-06 
21 lsoform 1 of Non-
POU domain-
containing 
octamer-binding - 70 kDa 
protein IPJ00320016.7 2 1.02E-06 
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Catalase, CAT, (Table 3. no. 4), is a common enzyme found in almost all 
living organisms exposed to oxygen. It catalyzes the decomposition of hydrogen 
peroxide to oxygen and water. It thereby protects the cell from oxidative damage by 
reactive oxygen species (ROS).23 Putative uncharacterized protein (Table 3. no. 5) 
is a protein whose function is unknown at this time and was, therefore, not 
considered in this analysis. Carboxylesterase 3, CES3, (Table 3. no. 6), is also an 
enzyme involved in the decomposition of hydrogen peroxide. It protects the cell 
from oxidative damage by reactive oxygen species (ROS). CES3 and CAT are usually 
found in peroxisomes but have also been reported in mitochondria.23 
Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, 
ALDH6A1, (Table 3. no. 7), belongs to the family of aldehyde dehydrogenases. It 
plays a role in valine and pyrimidine metabolism by catalyzing the irreversible 
oxidative decarboxylation of malonate and methylmalonate semialdehydes to 
acetyl-and propionyl-CoA. 24 Protein disulfide-isomerase A3, PDIA3, (Table 3. no. 
8), is found in the endoplasmic reticulum in eukaryotes and catalyzes the formation 
and breakage of disulfide bonds between cysteine residues within proteins as they 
fold. 25 It is worthwhile to note that the OMM comes into contact with the 
endoplasmic recticulum. This hit is also intriguing because the crystal structures of 
mitoNEET show no evidence of disulfide bond formation although the Konkle lab 
identified that mitoNEET may form a disulfide bond between monomers.20 
Isoform 1 of 60 kDa heat shock protein, mitochondrial, HSPDl, (Table 3. no. 
9), is implicated in mitochondrial protein import and macromolecular assembly. It 
22 
may help to prevent misfolding of proteins by promoting proper assembly of 
unfolded polypeptides that are generated under stress conditions in the 
mitochondrial matrix.26 This is another protein that plays a significant role in the 
cell during oxidative stress. Aldh4a1, (Table 3. no. 10), is a member of the aldehyde 
dehydrogenase family. It is found in the mitochondria and is an NAO-dependent 
dehydrogenase that helps to catalyze the second step of the praline degradation 
pathway by converting pyrroline-5-carboxylate to glutamate.27 This action would 
contribute or subtract from the amount of glutamate in the mitochondria. 
Interestingly, another hit on the list, Delta-lpyrroline-5-carboxylate dehydrogenase, 
mitochondrial (Table 3. no. 12), has been found to be the same enzyme as Aldh4a1. 
Heterogeneous nuclear ribonucleoprotein L, HNRNPL, (Table 3. no. 11), 
complexes are the structures that contain hnRNAs and their associated proteins. 
They provide the substrate for the processing that pre-mRNAs undergo before 
becoming functional in the cytoplasm.28 At this time, there is no information known 
about the stability or lifetime of mitoNEET mRNA. Isoform 1 of Acyl-coenzyme A 
synthetase, ACSMl, (Table 3. no. 13), mitochondrial, is part of the mitochondrial 
matrix and functions as a GTP-dependent lipoate-activating enzyme that generates 
the substrate for lipoyltransferase.29 Conjugated lipoyl derivatives are cofactors of a 
number of enzymes. 
Glutamate dehydrogenase 1, mitochondrial, GLUDl, (Table 3. no. 14), is a 
mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate 
to alpha-ketoglutarate and ammonia. It also regulates amino acid induced insulin 
secretion through the AMPK pathway. GLUDl is allosterically activated by ADP and 
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leucine while it is inhibited by GTP and ATP.30 Amine oxidase [flavin-containing] B, 
MAOB, (Table 3. no. 15) is found in the outer mitochondrial membrane and 
functions in the metabolism of neuroactive and vasoactive amines and 
neurotransmitters in the central nervous system and peripheral tissues. It also 
catalyzes the oxidative deamination of biogenic and xenobiotic amines. It degrades 
benzylamine and phenylethylamine, normetepinephine to 4-0H-3-methoxy-D-
mandelate. 31 2-hydroxyacyl-CoA lyase 1, HACL1, (Table 3. no. 16), is a 
peroxisomal enzyme that has been found in mammals that is dependent on thiamine 
pyrophosphate (TPP). It plays an important role in the degradation of 3-
methylbranched fatty acids and the shortening of 2-hydroxy long-chain fatty acids.32 
MCG23407, (Table 3. no. 17), has no information available at this time and was, 
therefore, not considered in this analysis. 
Calreticulin, CALR, (Table 3. no. 18), is a multifunctional protein that acts as 
a major Ca2+ binding (storage) protein in the lumen of the endoplasmic reticulum. It 
is also found in the nucleus, suggesting it may be part of transcription regulation.33 
Beta-globin or hemoglobin, (Table 3. no. 19), probable contamination. 
Choline dehydrogenase, mitochondrial, CHDH, (Table 3. no. 20), is a protein 
which catalyzes the reversible conversion of choline (a neurotransmitter) to betaine 
aldehyde (an intermediate in amino acid metabolism) .34 Isoform 1 of Non-POU 
domain-containing octamer-binding protein, NONO, (Table 3. no. 21), is a DNA and 
RNA binding protein that is involved in several nuclear processes. It binds the 
conventional octamer sequence in double-stranded DNA. It also binds single-
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stranded DNA and RNA at a site independent of the duplex site.35 It is unclear how 
mitoNEET could be involved in DNA/RNA processing at this time. 
T bl 4 P a e f 1 4 roteom1c resu ts rom samp e 
Protein Protein MWappt ID EC Peptides q value 
Number Annotation Number Number Identified 
22 Glutamate 
dehydrogenase 
1, mitochondrial - 75 kDa IPI00114209.l 1.4.1.3 SS 3.37E-06 
23 Aldehyde 
dehydrogenase, 
mitochondrial - 75 kDa IPI00111218.1 1.2.1.3 18 3.37E-06 
24 Methylmalonate-
semialdehyde 
dehydrogenase 
[ acylating], 
mitochondrial - 75 kDa IPI00461964.3 1.2.1.27 13 3.31E-06 
2S Catalase 
- 75 kDa IPI00869393.l 1.11.1.6 7 2.29E-06 
26 Serine 
hydroxymethyltr 
ansferase - 75 kDa IPI004S4008.l 2.1.2.1 7 2.19E-06 
27 Carboxylesterase 
- 75 kDa 
3 IPI00387289.3 3.1.1.1 4 l.19E-06 
28 Jsoform 1 of 
Dihydrolipoyllysi 
ne-residue 
succinyltransfera 
se component of 
2-oxoglutarate 
dehydrogenase 
complex, 
mitochondrial - 7S kDa IPI00134809.2 2.3.1.61 2 2.29E-06 
29 Dimethylaniline 
monooxygenase 
[N-oxide- - 75 kDa 
formingl 1 IPI00116432.1 1.14.13.8 2 0.0001 
Glutamate dehydrogenase 1, mitochondrial, GLUD1, (Table 4. no. 22), 
duplicate, (see Table 3. no. 14). Aldehyde dehydrogenase, mitochondrial, ALDH2, 
(Table 4. no. 23), is a polymorphic enzyme involved in alcohol metabolism that 
catalyzes the oxidation of aldehydes to carboxylic acids.36 
Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, 
MM-ALDH, (Table 4. no. 24), is an enzyme responsible for the oxidative 
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decarboxylation of malonate and methylmalonate semialdehydes to acetyl-and 
propionyl-CoA in the pyrimidine catabolic pathway.37 Pyrimidine is an intermediate 
in nucleic acid synthesis. Catalase (Table 4. no. 25), duplicate, (see Table 3. no. 4). 
Serine hydroxymethyltransferase, SHMT2, (Table 4. no. 26), is a gene that encodes 
the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes 
the reaction of serine and tetryhydrofolate. The encoded product is primarily 
responsible for glycine, and amino acid, synthesis.38 Carboxylesterase 3 (Table 4. 
no. 27), is a duplicate (see Table 3. no. 6). 
Isoform 1 of Dihydrolipoyllysine-residue succinyltransferase component 2-
oxoglutarate dehydrogenase complex, mitochondrial, DLST, (Table 4. no. 28), 
belongs to the 2-oxoacid dehydrogenase family. It catalyzes the overall conversion 
of alpha-ketoglutarate to succinyl-CoA and COz.39 Dimethylaniline monooxygenase 
[N-oxide-forming] 1, FM01, (Table 4. no. 29), is involved in the oxidative 
metabolism of a variety of xenobiotics. The liver is the primary site for the 
detoxification/metabolism of xenobiotic compounds. Form I catalyzes the N-
oxygenation of secondary and tertiary amines. 40 
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Proteomics Results - Human Hepatocarcinoma Cell Lysate 
A second pull-down experiment was done ~ 
I 81.11 + Pr"Y 
2 Bait + Prey 
J Bait 
using human hepatocarcinoma cells 
(HepG2) lysate and human mitoNEET. 
Bands were selected in a similar manner as 
the mouse bands (Figure 13.). The bands at 
4 l'!t) 
.S. Wash SttVS 
6 MW Ladder 
-70 (Table 6.) and 75 kDa (Table 7.) were 
Figure 13: Pull -down gel results from 
th e HepG2 lysate. MitoNEET and HepG2 
lysate in sampl e 1 and 2, the mitoNEET 
control in sample 3, the HepG2 lysate 
control in sample 4, wash elution steps in 
sample 5, and the molecular weight 
ladder in sam le 6. 
excised and submitted for proteomic analysis. However, an additional band of -37 
kDa (Table 5.), that was unique to the bait-prey lane was observed and analyzed. 
Proteomic Results Tables (Human) 
T bl 5 P a e f roteom1c resu ts rom samp e 5 
Protein Protein MWapp1 ID EC Peptides q value 
Number Annotation Number Number Identified 
1 Glyceraldehyde-
3-phosphate 
dehydrogenase - 37 kDa IPI00219018.7 1.2.1.12 26 O.OOE+OO 
2 Aldo-keto 
reductase family 
1 member Cl - 37 kDa IPI00029733.1 1.1.1.- 22 1.12E-07 
3 Isoform 2 of 
Nucleophosmin - 37 kDa IPI00220740.1 12 2.33E-11 
4 Mal ate 
dehydrogenase, 
mitochondrial - 37 kDa IPI00291006.2 1.1.1.37 9 2.33E-11 
5 Fructose-
biphosphate 
aldolase A - 37 kDa IPI00465439.5 4.1.2.13 7 2.38E-10 
6 Actin, 
cytomplasmic 1 - 37 kDa IPI00021439.1 7 1.25E-10 
7 Qui none 
oxidoreductase - 37 kDa IPI00000792.1 1.6.99.2 5 8.70E-11 
8 Aspartate 
aminotransferase, 
mitochondrial - 37 kDa IPI00018206.3 2.6.1.1 6 O.OOE+OO 
9 Ma late 
dehydrogenase, 
cytoplasmic - 37 kDa IPI00291005.8 1.1.1.37 6 1.16E-09 
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10 Similar to 
nucleophosmin - 37 kDa IPJ00455423.4 4 3.95E-05 
11 Mitogen-activated 
protein kinase 1 - 37 kDa IPI00003479.3 2.7.11.24 4 2.45E-05 
12 Tansaldolase 
- 37 kDa IPJ00072377.1 2.2.1.1 3 5.61E-13 
13 Isoform 1 of 
Protein SET - 37 kDa IPJ00072377.1 2.1.1.43 4 9.14E-12 
14 DNA-(apurinic or 
apyrimidinic site) 
Iyase - 37 kDa IPJ00215911.3 4.2.99.18 3 7.54E-08 
15 Fructose-
bi phosphate 
aldolase - 37 kDa IPJ00418262.5 4.1.2.13 3 1.27E-06 
16 lsoform Bl of 
Heterogeneous 
nuclear 
ribonucleoprotein - 37 kDa IPJ00396378.3 4 1.31E-05 
17 Mitogen-activated 
protein kinase 3 - 37 kDa IPJ00018195.3 2.7.11.24 3 6.88E-05 
18 Aspartate 
aminotransferase, 
cytoplasmic - 37 kDa IPJ00219029.3 2.6.1.1 2 6.33E-11 
Glyceraldehyde-3-phosphate dehydrogenase, GADPH, (Table 5. no. 1), is a 
metabolic enzyme that catalyzes the conversion of glyceraldehyde 3-phosphate to 
D-glycerate 1, 3-biphosphate in glycolysis. 41 Additionally, GAPDH has been shown 
to have a number of additional functions in protein expression regulation and the 
progression of type-2 diabetes. Aldo-keto reductase family 1 member Cl, AKR1C1, 
(Table 5. no. 2), is a member of the aldo/keto reductase superfamily. AKR1C1 
catalyzes the conversion of aldehydes and ketones to their corresponding alcohols 
by using NADH and/or NADPH as their cofactors.42•43 
There are several functions of isoform 2 of nucleophosmin, NPM 1, (Table 5. 
no. 3), that have been noted. One of these is a cellular process of ribosome 
biogenesis, protein chaperoning, histone assembly, cell proliferation and regulation 
of tumor suppressors p53/TPS3 and ARF.44 The importance of tumor suppression 
p53 in cancer progression cannot be overstated. 
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Malate dehydrogenase, MDH2, (Table 5. no. 4), is an enzyme that catalyzes 
the reversible oxidation of malate to oxaloacetate using the reduction of NAD+ to 
NADH in the citric acid cycle in the mitochondria.45 Fructose-biphosphate aldolase A, 
ALDOA, (Table 5. no. 5), is a glycolytic enzyme that catalyzes the reversible 
conversion of fructiose-1,6-biphosphate to glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate.46 Actin Cytoplasmic 1 (Table 5. no. 6) and quinone 
oxidoreductase (Table 5. no. 7) are probable contaminats from sample handling. 
Aspartate aminotransferase, mitochondrial, also called glutamic-oxaloacetic 
transaminase 2, GOT2, (Table 5. no. 8), is a pyridoxal phosphate-dependent enzyme 
that exists in membrane and cytoplasmic mitochondrial forms. This enzyme plays a 
role in amino acid metabolism and urea and tricarboxylic acid cycles, L-aspartate to 
2-oxoglutarate aminotransferase activity and L-phenylalanine to 2-oxoglutarate 
aminotransferase activity.47 Malate dehydrogenase, cytoplasmic, MDH1, (Table 5. 
no. 9) catalyzes the reversible oxidation of malate to oxaloacetate utilizing the 
NAD/NADH cofactor system in the citric acid cycle.45 Both MDH enzymes are 
involved in the malate/aspartate shuttle which enables the transport of NAD(H) 
across the IMM from the cytoplasm into the mitochondrial matrix. 
Nucleophosmin, NPM1, (Table 5. no. 10), has been found to be involved in 
many cellular processes, such as ribosome biogenesis and transport, histone 
chaperone, and genomic stability and its product is thought to be involved in the 
regulation of the ARF /p53 pathway.48 Mitogen-activated protein kinase 1, MAPK1, 
ERK2, (Table 5. no. 11), is a member of the MAP kinase family. It is involved in a 
variety of cellular processes such as proliferation, differentiation, transcription 
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regulation and development. The activation of this requires phosphorylation by 
upstream kinases. 49 Both NMPl isoforms and MAPKl are identified as important in 
carcinogenesis. 
Transaldolase, TALDOl, (Table 5. no. 12), is an enzyme in the non-oxidative 
phase of the pentose phosphate pathway. It provides ribose-5-phosphate for 
nucleic acid synthesis and NADPH for lipid biosynthesis. 50 Isoform 1 of Protein SET, 
SET, (Table 5. no. 13), inhibits acetylation of nucleosome by histone acetylases 
(HAT). Histone lysines which are masked from being acetylated, halt HAT-
dependent transcription. It can also enhance DNA replication of the adenovirus 
genome. 51 DNA-(apurinic or apyrimidinic site(AP) lyase, APEXl, (Table 5. no. 14), 
AP sites occur frequently in DNA molecules through spontaneous hydrolysis, DNA 
damaging agents or glycosylases that remove the abnormal bases. It accomplishes 
this by cleaving the carbon-oxygen bonds. 52 
Fructose-biphosphate aldolase, ALDOC, (Table 5. no. 15), is a glycolytic 
enzyme that catalyzes the reversible aldol cleavage of fructose-1,6-biphosphate and 
fructose 1-phosphate to dihydroxyacetone phosphate and either glyceraldehyde-3-
phosphate or glyceraldehyde. 53 The next proteomic hit belongs to a subfamily of 
expressed heterogeneous nuclear ribonucleoproteins (hnRPs) (Table 5. no. 16). 
These are RNA binding proteins and are associated with pre-mRNAs in the nucleus 
and influence pre-mRNA processing and other aspects of mRNA metabolism and 
transport. 54 
Mitogen-activated protein kinase 3, MAPK3, (Table 5. no. 17) is a member of 
the MAP kinase family, also known as extracellular signal-regulated kinase (ERKs). 
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It acts as a signaling cascade that regulates various cellular processes such as 
proliferation, differentiation and cell cycle progression in response to a variety of 
extracellular signals. It phosphorylates nuclear targets by translocating to the 
nucleus by upstream kinases. 55 The MAPK pathway is highly studied for its role in 
carcinogenesis. 
T bl 6 P t a e ro eom1c resu It f s rom sam I 6 J. e 
Protein Protein MWappt ID EC Peptides q value 
Number Annotation Number Number Identified 
19 Protein disulfide-
isomerase - 70 kDa IPI00010796.1 5.3.4.1 28 4.73E-06 
20 Glutamate 
dehydrogenase 1, 
mitochondrial - 70 kDa IPI00016801.1 1.4.1.3 23 7.81E-07 
21 Retinal 
dehvdrogenase 1 - 70 kDa IPI00218914.5 1.2.1.36 16 7.81E-07 
22 Calreticulin 
- 70 kDa IPI00020599.1 13 1.93E-06 
23 Glucose-6-
phosphate 
isomerase - 70 kDa IPI00908881.1 5.3.1.9 13 1.93E-06 
24 Isoform 1 of 
Polyadenylate-
binding protein 1 - 70 kDa IPI00008524.1 8 3.35E-07 
25 UDP-glucose 6-
dehvdrogenase - 70 kDa IPI00008524.1 1.1.1.22 8 3.35E-07 
26 Catalase - 70 kDa IPI00465436.4 1.11.1.6 8 7.33E-06 
27 Non-POU domain-
containing 
octamer-binding 
protein - 70 kDa IPI00304596.3 9 2.18E-05 
28 60 kDa heat shock 
protein, 
mitochondrial - 70 kDa IPI00784154.1 6 9.72E-06 
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aldehyde 
dehydrogenase 7 
family, member Al - 70 kDa IPI00221234.7 1.2.1.31 6 1.51E-06 
30 Serine 
hydroxymethyltran 
sferase, mitochon. - 70 kDa IPI00002520.1 2.1.2.1 5 7.33E-06 
31 Delta-1-pyrroline-
5-carboxylate 1.5.1.12 
dehydrogenase, /1.2.1.8 
mitochondrial - 70 kDa IPI00217871.4 8 4 1.llE-05 
31 
32 I so form 
Mitochondrial of 
Glutathione 
reductase, - 70 kDa IPI00016862.1 1.8.1.7 4 1.llE-05 
33 Isoform alpha- - 70 kDa 
enolase of Alpha-
enolase IPI00465248.5 4.2.1.11 3 3.38E-05 
34 Isoform 2 of 
Basie:in - 70 kDa IPI00019906.1 2.7.1.37 3 7.33E-06 
35 ATP synthase 
subunit alpha, 
mitochondrial - 70 kDa IPI00440493.2 3.6.3.14 2 0.0002 
Protein disulfide-isomerase, PDIA1, (Table 6. no. 19), is a multifunctional 
protein that catalyzes the formation rearrangement and breakage of disulfide bonds 
between cysteine residues within proteins as they fold. 56 Glutamate dehydrogenase 
1, mitochondrial, GLUD1, (Table 6. no. 20), is a mitochondrial matrix enzyme that 
catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and 
ammonia. It also helps regulate amino acid induced insulin secretion. It is 
allosterically activated by ADP and inhibited by GTP and ATP.30 
Retinal dehydrogenase 1, ALDH1A1, (Table 6. no. 21), belongs to the 
aldehyde dehydrogenase family. Aldehyde-dehydrogenase is the next enzyme after 
alcohol dehydrogenase in the alcohol metabolism pathway and can convert 
retinaldehyde to retinoic acid. s7 Calreticulin, CALR, (Table 6. no. 22), duplicate, 
(see Table 3. no. 18). Glucose-6-phosphate isomerase, GPI, (Table 6. no. 23), is an 
enzyme that catalyzes the conversion of glucose-6-phosphate to fructose-6-
phosphate in the second step of glycolysis. 58 
Isoform 1 of Polyadenylate-binding protein 1, PABPC1, (Table 6. no. 24 ), 
binds to poly( A) promoting ribosome recruitment and translation initiation. It is 
also required for poly( A) shortening which is the first step in mRNA decay. 59 UDP-
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glucose 6-dehydrogenase, UGDH, (Table 6. no. 25), converts UDP-glucose to UDP-
glucuronate and participates in the biosynthesis of glycosaminoglycans. These 
glycosylated compounds are components of extracellular matrix and participates in 
signal transduction, cell migration and cancer growth, and metastasis. 6° Catalase, 
CAT, (Table 6.no. 26) is a duplicate of the mouse results, (see Table 3. no. 4). 
Non-POU domain-containing octamer-binding protein, (Table 6. no. 27), 
has limited information available at this time. 60 kDa heat shock protein, 
mitochondrial, HSPDl, (Table 6. no. 28), is a member of the chaperonin family. It is 
essential for the folding and assembly of newly imported proteins in the 
mitochondria. 61 Aldehyde dehydrogenase 7 family, member Al, ALDH7 Al, (Table 
6. no. 29), is a member of the aldehyde dehydrogenase (ALDH) gene family. It plays 
a major role in the detoxification of aldehydes generated by alcohol metabolism and 
lipid peroxidation. It also converts 2-aminoadipate semialdehyde to 2-
aminoadipate. 62 
Serine hydroxymethyltransferase, mitochondrial, SHMT2, (Table 6. no. 30), 
this enzyme contributes to catalyzing the reversible, simultaneous conversions of L-
serine to glycine and tetrahydrofolate to 5, 10-methylenetetrahydrofolate. 63 Delta-
1 pyrroline-5-carboxylate dehydrogenase, mitochondrial, ALDH4Al, (Table 6. no. 
31), belongs to the aldehyde dehydrogenase family, which catalyzes the second step 
of the proline degradation pathway by converting 3-hydroxy pyrroline-5-
carboxylate to 4-hydroxyglutamate. 64 Isoform Mitochondrial of Glutathione 
reductase, mitochondrial, GSR, (Table 6. no. 32), is a homodimeric flavoprotein. It 
is a central enzyme of cellular antioxidant defense and reduced oxidized glutathione 
33 
disulfide (GSSG) to the sulfhydryl form (GSH). It is also a member of the class-1 
pyridine nucleotide-disulfide oxidoreductase family. 65 lsoform one of alpha-
enolase, ENOl, (Table 6. no. 33), is a glycolytic enzyme involved in the reversible 
conversion of phospo-enolpyruvate to 2-phospho-glycerate. 66 Isoform 2 of Basigin, 
BSG, (Table 6. no. 34), is a member of the immunoglobulin superfamily and is a 
possible contaminant from sample handling. 
ATP synthase subunit alpha, mitochondrial, ATPSAl, (Table 6. no. 35), 
catalyzes ATP synthesis by using an electrochemical gradient of protons across the 
inner membrane during oxidative phosphorylation. Composed of two linked multi-
subunit complexes, the soluble, catalytic core, F1 and the membrane-spanning 
component, Fo, comprising the proton channel, the ATPase is the terminal enzyme in 
oxidative phosphorylation. 67 
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T bl 7 P a e roteom1c resu ts f rom sam I 7 J. e 
Protein Protein MWappt ID EC Peptides q value 
Number Annotation Number Number Identified 
36 Isoform 1 of Heat 
shock cognate 71 
kDa protein - 75 kDa IPI00003865.1 23 1.71E-10 
37 cDNA FLJ54957 
highly similar to 
Transketolase - 75 kDa IPI00643920.3 2.2.1.1 14 1.20E-06 
38 Stress-70 protein, 
mitochondrial 
- 75 kDa IPI00007765.5 8 4.53e-10 
39 lsoform 1 of 
Polyadenylate-
binding proteinl - 75 kDa IPI00008524.1 7 2.20E-12 
40 Isoform A of 
Lamin-A/C - 75 kDa IPI00021405.3 5 5.99E-07 
41 lsoform 1 of 
Cytoskeleton-
associated protein 
4 - 75 kDa IPI00141318.2 2.7.10.1 4 2.02E-10 
42 HSPAS protein - 75 kDa IPI00003362.2 3 3.41E-07 
43 Dolichyl-
diphosphooligosac 
charide-protein 
glycosyltransferase 
subunit 1 
precursor - 75 kDa IPI00025874.2 2.4.99.18 3 2.55E-06 
44 Stress-induced- IIPI00013894. 
phosphoprotein 1 - 75 kDa 1 6.3.2.- 3 3.70E-07 
45 Isoform 1 of 
Paraspeckle 
component 1 - 75 kDa IPI00103525.1 3 3.80E-05 
46 cDNA FLJ78440, 
highly similar to 
Human lactoferrin - 75 kDa IPI00298860.6 3.4.21.- 2 3.26E-07 
47 lsoform 1 of 
Apoptosis-inducing 
factor 1, 
mitochondrial - 75 kDa IPI00000690.1 1.1.1.- 2 4.06E-06 
47 lsoform 1 of 
Heterogeneous 
nuclear 
ribonucleoprotein 
Q - 75 kDa IPI00018140.3 2 4.62E-06 
48 Apolipoprotein E - 75 kDa IPI00021842.1 2 8.55E-05 
50 Isoform 1 of 
Probably ATP-
dependent RNA 
helicase DDXl 7 - 75 kDa IPI00023785. 7 3.6.4.13 2 0.0296 
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Isoform 1 of Heat shock cognate 71 kDa protein, HSPA8, (Table 7. no. 36 ), is 
a member of the heat shock protein 70 family. It is believed to function as a 
chaperone and binds to nascent polypeptides to facilitate correct folding. 68 cDNA 
FLJ4957, highly similar to Transketolase, TKT, (Table 7. no. 37), encodes a 
thiamine-dependent enzyme which helps the channeling of excess sugar phosphates 
to glycolysis in the pentose phosphate pathway. It catalyzes D-ribose-5-phosphate 
to 3-phospho-glyceraldehyde. 69 Stress-70 protein, mitochondrial, HSPA9, (Table 7. 
no. 38), is a heat-shock cognate protein that plays a roll in cell proliferation, stress 
response and maintenance of the mitochondria. It is a member of the heat shock 
protein 70 family. 70 
Isoform 1 of Polyadenylate-binding protein 1, (Table 7. no. 39) duplicate hit, 
(see Table 6. no. 24). Isoform A of Lamin-A/C, (Table 7. no. 40) is a protein of 
unknown function. lsoform 1 of Cytoskeleton associated protein 4, CKAP4, (Table 7. 
no. 41), mediates the anchoring of the endoplasmic reticulum to microtubules. It is 
a high-affinity epithelial cell surface receptor for APF. 71 HSPAS protein, (Table 7. 
no. 42), is a member of the heat shock protein 70 family. Localized in the lumen of 
the endoplasmic reticulum (ER), it is involved in the folding and assembly of 
proteins in the ER. 72 Dolichyl-diphosphooligosaccharide-protein 
glycosyltransferase subunit 1 precursor, also known as ribophorin, RPN1, (Table 7. 
no. 43), is an essential subunit of the N-oligosaccharyl transferase (OST) complex 
which catalyzes the transfer of a high mannose oligosaccharide from lipid-linked 
oligosaccharide donor to an asparagine residue in nascent polypeptide chains. 73 
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Stress-Induced-phosphorprotein 1, STIP1, (Table 7. no. 44), is an adaptor 
protein that coordinates the functions of HSP70 and HSP90 in protein folding. It is 
also thought to assist in the transfer of proteins from HSP70 to HSP90 by binding 
both HSP90 and substrate-bound HSP70. It stimulates the ATPase activity of HSP70 
and inhibits the ATPase activity of HSP90. This suggests that it regulates both of the 
conformations and the ATPase cycles of these chaperones. 74 
Isoform 1 of paraspeckle component 1(Table7. no. 45) and cDNA 
FLJ78440, highly similar to Human lactoferrin, (Table 7. no. 46) are proteins of 
unknown origin. 
Isoform 1 of Apoptosis-inducing factor 1, mitochondrial, AIFM1, (Table 7. 
no. 46) is a flavoprotein essential for nuclear disassembly in apoptotic cells, and is 
found in the mitochondrial intermembrance space in healthy cells. It also plays a 
key role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed 
cells. 7s Isoform 1 of Heterogeneous nuclear ribonucleoprotein Q, SYNCRP, (Table 7. 
no. 48), belongs to the cellular heterogeneous nuclear ribonucleoprotein (hnRNP) 
family. It is implicated in the mRNA processing mechanisms. 76 Apolipoprotein E, 
(Table 7. no. 49) and Isoform 1 of Probably ATP-ependent RNA helicase DDXl 7, 
(Table 7. no. 50) resulted from probable contamination during sample handling .. 
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Discussion 
Three separate areas were chosen to find protein interactions with 
mitoNEET. These include: metabolic pathway (Table 8.), stressors (Table 9.), and 
signal pathway; cancer (Table 10.). There were 50 human proteins and 29 mouse 
proteins identified. Of these, 49 were excluded in the results due to duplication, 
contamination, or information not being found. Interestingly, there were several 
duplicates that were found not only within the same species, but in both species. 
These include calreticulin, catalase, delta-1-pyrroline-5-carboxylate dehydrogenase, 
glutamate dehydrogenase and serine hydroxymethyltransferase. 
Glucose metabolism is responsible for producing energy for a cell. 
Organisms that require oxygen to produce ATP, a coenzyme used for energy 
transfer or aerobic respiration, metabolize glucose and oxygen to release energy 
with byproducts of carbon dioxide and water. The conversion of glucose molecules 
to pyruvate in order to obtain ATP is known as glycolysis, which mainly takes place 
in the cytosol. Four proteins (Table 8.) were found to be involved in this process. 
Glucose can be generated from pyruvate, in the liver, through gluconeogenesis. Five 
of the proteins identified (Table 8.) were a part of this process. In the mitochondria 
of aerobic organisms, energy and carbon dioxide are produced through the 
oxidation of acetate that has been derived from carbohydrates and fats through the 
citric acid cycle. Three of the proteins (Table 8.) are active in this pathway. In the 
oxidative phosphorylation pathway, ATP is reformed through the oxidation of 
nutrients found in the mitochondria. One protein (Table 8.) was found to be 
involved in this process. 
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Figure 14: Chemical 
structure of glutamate. 
Chem Works 
Amino Acids are basic building blocks of proteins and are 
classified in many different ways based on their core 
structural group and side-chain groups. Functions of amino 
acids may include neurotransmission and biosynthesis. In 
proteins, they are the largest components of cells. Three of 
the proteins found (Table 8.) are involved in amino acid biosynthesis. Glutamate 
(Figure 14.) has many biochemical functions including 
cellular energy and protein synthesis. It can also be used 
as a nitrogen donor in anabolic processes. Proline (Figure 
15.) is an amino acid that the body can synthesize that is 
derived from L-glutamate. It is commonly found in the 
secondary structures, the alpha 
OJ-OH 
CNH 
Proline 
Figure 15: Chemical 
structure of pro line. 
Chem Works. CH3 0 
H3cVoH 
NH2 
helices and beta sheets. It is a DNA-encoded amino acid. 
Valine 
Figure 16: Chemical 
structure ofvaline. 
Chem Works 
Valine (Figure 16.) is an essential, branch-chain amino acid 
that is involved in protein building and helps to repair 
damaged tissues. Methylmalonate-semialdehyde 
dehydrogenase [acylating], mitochondrials plays a role in valine metabolism. 
Carbohydrate biosynthesis (Table 8.) is simply producing carbohydrates 
from the chemical reactions and metabolic pathways. In this particular case, being 
similar to transketolase, the pentose phosphate pathway would be involved. 
Choline degredation (Table 8.), through choline dehydrogenase, is involved 
in many pathways. It is also involved in gene expression through DNA methylation. 
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Catecholamines (Table 8.) are derived from the amino acid tyrosine. Amine 
oxidase functions in the metabolism of vasoactive amines and some are bound to 
plasma proteins in the bloodstream. Retinal metabolism (Table 8.), which retinal 
dehydrogenase is a cofactor binds free retinal and cellular retinal-binding protein-
bound retinal. Folic acid pool (Table 8.) are involved in the transfer of 1 carbon 
units by using serine hydroxymethyltransferase. 
Table 8 Metabolic Enzymes 
Name E.C.Number Metabolic Pathwav 
Malate dehydrogenase, Citric Acid Cycle 
mitochondrial, cytoplasamic 1.1.1.37 Gluconeogenesis 
Glyceraldehyde-3-phosphate Glycolysis and 
dehydrogenase 1.2.1.12 Gluconeogenesis 
Fructose-biphosphate Glycolysis and 
al do lase 4.1.2.13 Gluconeogenesis 
Aldehyde dehydrogenase Glycolysis and 
mitochondrial 1.2.1.3 Gluconeogenesis 
lsoform alpha-enolase of Glycolysis and 
Alpha enolase 4.2.1.11 Gluconeogenesis 
Glutamate dehydrogenase 1, Citric Acid Cycle and 
mitochondrial Amino Acid Biosynthesis 
1.4.1.2 ( e:lutamate) 
Aspartate aminotransferase, Citric Acid Cycle and 
mitochondrial, cytoplasmic Amino Acid Biosynthesis 
2.6.1.1 (glutamate) 
ATP synthase subunit alpha, Oxidative 
mitochondrial 3.6.3.14 phosphorylation 
ALDH4Al Amino Acid Biosynthesis 
Delta-1-pyrroline-5- (praline) 
carboxylate dehydrogenase, 
mitochondrial 1.5.1.12 
Methylmalonate- Amino Acid Biosynthesis 
semialdehyde (valine) 
dehydrogenase [ acylating], 
mitochondrial 1.2.1.18 
Choline dehydrogenase, Choline degradation 
mitochondrial 1.1.99.1 
cDNA FLJ54957, highly Carbohydrate 
similar to Transketolase 2.2.1.1 biosynthesis 
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UD P-glucose-6- Carbohydrate 
dehvdrogenase 1.1.1.22 biosvnthesis 
Amine oxidase [flavin-
containin~ l B 1.4.3.4 Catecholamines 
Retinal Dehvdrogenase 1 1.2.1.36 Retinol metabolism 
Serine 
hydroxymethyltransferase, 
mitochondrial 2.1.2.1 Folic Acid Pool 
Protein folding involves many enzymes and chaperones in order to regulate 
reactions. Two of the most important are disulfide bond formation and N-linked 
glycosylation. The endoplasmic reticulum recognizes when a misfolding occurs and, 
without disruption to the ER, will guide the misfold through ER 
degradation77(Table 9.). Catalase and glutathione peroxidase (Table 9.) protect the 
organism from oxidative damage.22 Formation of hydrogen peroxide or larger 
molecules, hydroperoxides, can be very harmful to cells. 
A mutation in the aldehyde dehydrogenase 7-family (Table 9.) has been 
known to cause phydridoxine-dependent epilepsy.62 This mutation causes the 
production of a nonfunctional antiquitin protein. A shortage of this protein can 
cause a disruption in pyridoxine activity, which plays a role in many processes such 
as the breakdown of amino acids in the body. 
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Table 9 Cellular Stress Response 
Name Stressor 
Calreticulin Misfolded proteins 
Catalase H202 
Glutathione peroxidase H202/hydroperoxides 
60 kDa heat shock protein, 
mitochondrial Misfolded proteins 
Isoform 1 of heat shock cognate 71 kDa 
protein Misfolded proteins 
HSPAS protein Misfolded proteins 
Stress-70 protein, mitochondrial Misfolded proteins 
Aldehyde dehydrogenase 7 family, 
member Al Pyridoxine-dependent 
Isoform Mitochondrial of Glutathione Thioredoxin system-absence of 
reductase, mitochondrial glutathione reductase 
Data indicates mitoNEETs possible interaction with cancer cell signaling 
pathways (Table 10.). These include possible promotion of tumor growth, gene 
mutation and binding disruption. Their pathways neatly fit into cancer hallmark 
categories of sustaining proliferative signaling, evading growth suppressors, 
activating invasion and metastasis, enabling replicative immortality, inducing 
angiogenesis and resisting cell death.78 
Table 10 Cell Signaling/Cancer 
Name SiJznal Pathwav 
lsoform 2 of nucleophosmin Ribosome biogenesis protein 
Mitogen-activated protein kinase 1 MAPK's growth signaling 
Mitogen-activated protein kinase 3 MAPK's growth signaling 
lsoform 1 of polyadenylate-binding 
protein 1 Mistranslation initiation 
Isoform 1 of protein SET Apoptosis 
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Conclusion 
We found that the plot of the mystery of mitoNEET's function(s) only 
thickens. The observations that mitoNEET is a binding site for pioglitazone, has the 
ability to transfer the [2Fe-2S] cluster, participate in electron transport, and 
regulate oxidative respiration are helpful. However, the mechanisms of these 
functions and their role in the cellular physiology remain unclear. Our pull-down 
experiments indicate that mitoNEET may have interaction(s) with metabolic 
pathway proteins, stress proteins and proteins involved in cancer cell signaling are 
promising. 
Characterizing proteins often requires the process of protein purification, 
which is a painstaking task that involves many steps and trials to optimize. Certain 
procedures are available in order to succeed in this endeavor. Persistence and 
patience become part of the overall process because it is very difficult to isolate 
certain proteins that are to be analyzed. Assays and analytical procedures are 
performed in order to quantitatively and qualitatively assess the target protein. 
Purified products need verification in order to ensure the correct protein has been 
isolated and identified. 
Through our pull down experiments and proteomic verification, we were 
able to determine protein binding partners of mitoNEET. Having verified the 
positive hit of glutamate dehydrogenase 1, we are one step closer to unraveling the 
the function(s) of mitoNEET and have shown that our pull-down results provide a 
solid experimental foundation. 
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